Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2025)

Sutro Biopharma has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.45 for Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.45, up 246.51% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.45 (up 246.51% YoY), and the FY2025 annual result was 0.37, up 152.6% from the prior year.
• Asset Utilization Ratio came in at 0.45 for Q4 2025 at Sutro Biopharma, up from 0.4 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.11 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.18 (2021), against an average of 0.23.
• Peak annual rise in Asset Utilization Ratio reached 246.51% in 2025, while the deepest fall reached 62.51% in 2025.
• Sutro Biopharma's Asset Utilization Ratio stood at 0.17 in 2021, then slipped by 3.33% to 0.17 in 2022, then soared by 103.0% to 0.34 in 2023, then sank by 62.12% to 0.13 in 2024, then surged by 246.51% to 0.45 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.45 (Q4 2025), 0.4 (Q3 2025), and 0.32 (Q2 2025), per Business Quant data.